SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-04-006365
Filing Date
2004-11-15
Accepted
2004-11-15 17:19:11
Documents
1
Period of Report
2004-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 10894
  Complete submission text file 0001140361-04-006365.txt   12986
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121 8584522323X131
KESSEL LARRY (Reporting) CIK: 0001199105 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 041146829